History of hypersensitivity to salicylates (including mesalazine) or any of the excipients of Mezavant XL.
Severe renal impairment (GFR <30 mL/min/1.73 m2) and/or severe hepatic impairment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education